SCHEMBL768465

SCHEMBL768465

O=C(O)C(S)CCCCCCCCCCCO

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNPEP Q9H4A4 3/20 0.61
FOLH1 Q04609 2/20 0.50
GPR84 Q9NQS5 4/20 0.42
FFAR1 O14842 2/20 0.42
FFAR4 Q5NUL3 1/20 0.42
PTPN1 P18031 1/20 0.38
CPB2 Q96IY4 1/20 0.36
CAMK2A Q9UQM7 1/20 0.35
MAPT P10636 2/20 0.34
LCK P06239 1/20 0.34
PPARD Q03181 1/20 0.34
ZDHHC20 Q5W0Z9 1/20 0.34
ZDHHC2 Q9UIJ5 1/20 0.34
GSTK1 Q9Y2Q3 1/20 0.33
ABCB11 O95342 1/20 0.33
F2 P00734 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6891450 0.98 RNPEP (0.64) RNPEPFOLH1GPR84FFAR1FFAR4
SCHEMBL11163066 0.90 RNPEP (0.73) RNPEPFOLH1GPR84FFAR1CPB2
SCHEMBL11161171 0.90 RNPEP (0.73) RNPEPFOLH1GPR84FFAR1CPB2
SCHEMBL11159608 0.87 RNPEP (0.76) RNPEPFOLH1GPR84FFAR1CPB2
SCHEMBL5476409 0.82 RNPEP (0.68) RNPEPFOLH1CPB2MAPTABCB11
SCHEMBL933573 0.81 RNPEP (0.61) RNPEPFOLH1GPR84FFAR1CPB2
SCHEMBL11363113 0.81 RNPEP (0.61) RNPEPFOLH1GPR84FFAR1CPB2
SCHEMBL5669221 0.81 RNPEP (0.61) RNPEPFOLH1GPR84FFAR1CPB2
Alcohol SCHEMBL28869290 0.80 GPR84 (0.55) RNPEPFOLH1GPR84FFAR1FFAR4
Alcohol SCHEMBL28216050 0.80 GPR84 (0.55) RNPEPFOLH1GPR84FFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8790934-B2 Nanoparticles CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2014-07-29 US disclosed
EP-1671625-B2 Nanoparticles CONSEJO SUPERIOR INVESTIGACION (ES) 2013-12-25 EP disclosed
US-20120071443-A1 NANOPARTICLES MIDATECH LIMITED (GB) 2012-03-22 US disclosed
US-7960555-B2 Substituted pyridine ligands and related water-soluble catalysts UNIVERSITY OF MASSACHUSETTS (US) 2011-06-14 US disclosed
EP-1671625-B1 Nanoparticles CONSEJO SUPERIOR INVESTIGACION (ES) 2010-05-19 EP disclosed
US-20090156767-A1 Substituted pyridine ligands and related water-soluble catalysts NAVY, SECRETARY OF THE UNITED STATES OF AMERICA 2009-06-18 US disclosed
US-20080269444-A1 PEG-Substituted Pyridine Ligands and Related Water-Soluble Catalysts EMRICK TODD S 2008-10-30 US disclosed
US-20080145441-A1 Core of metal atoms of gold, silver or copper covalently linked to a carbohydrate group and to at least 20 ligands MIDATECH LIMITED (GB) 2008-06-19 US disclosed
US-7364919-B2 Immobilization carbohydrates; calibration; diagnosis; antiinflammatory agents, bactericides MIDATECH LIMITED (GB) 2008-04-29 US disclosed
US-7332609-B2 PEG-substituted pyridine ligands and related water-soluble catalysts UNIVERSITY OF MASSACHUSETTS (US) 2008-02-19 US disclosed
US-20060235235-A1 PEG-substituted pyridine ligands and related water-soluble catalysts ENERGY, UNITED STATES DEPARTMENT OF 2006-10-19 US disclosed
EP-1671625-A1 Nanoparticles CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2006-06-21 EP disclosed
WO-2006045070-A2 PEG-SUBSTITUTED PYRIDINE LIGANDS AND RELATED WATER-SOLUBLE CATALYSTS UNIVERSITY OF MASSACHUSETTS (US) 2006-04-27 WO disclosed
EP-1326589-B1 NANOPARTICLES CONSEJO SUPERIOR INVESTIGACION (ES) 2006-03-08 EP disclosed
US-20040052729-A1 Immobilization carbohydrates; calibration; diagnosis; antiinflammatory agents, bactericides MIDATECH PHARMA PLC (GB) 2004-03-18 US disclosed
EP-1326589-A2 NANOPARTICLES CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2003-07-16 EP disclosed
WO-2002032404-A2 NANOPARTICLES CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2002-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156767-A1 Substituted pyridine ligands and related water-soluble catalysts MDM4, M6PR, PWWP2B RNPEP 2500/4885FOLH1 4354/4885GPR84 1913/4885
US-20060235235-A1 PEG-substituted pyridine ligands and related water-soluble catalysts PAM, EGFR, NAPEPLD RNPEP 1823/4885FOLH1 4429/4885GPR84 776/4885
US-20080269444-A1 PEG-Substituted Pyridine Ligands and Related Water-Soluble Catalysts PAM, EGFR, NAPEPLD RNPEP 1823/4885FOLH1 4429/4885GPR84 776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.